Health insurance coverage differences account for nearly one-half of the black-white survival disparity in colorectal cancer patients, according to a...

VANCOUVER, WASHINGTON (November 14, 2017) - Newly published research provides preclinical proof-of-concept for the ability of PRO 140, a humanized...

Credit: Journal of Hepatology Amsterdam, November 14, 2017 - Nonalcoholic fatty liver disease (NAFLD) is one of the more common...

Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several new treatments are available, they...

Credit: University of Delaware/ Wenbo Fan Doctors have many weapons in the fight against cancer, but choosing the right one...

PITTSBURGH, Nov. 13, 2017 - When low-income adults were newly covered by Medicaid under the Affordable Care Act (ACA), they...

The Telomere and Telomerase Group at the Spanish National Cancer Research Centre (CNIO) has shown that it is possible to...

The University of California, Davis, and the Leibniz Institute for Photonic Technologies in Jena, Germany, have entered an agreement of...

Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer - and it could open up...

PHILADELPHIA -- (Nov. 13, 2017) -- Researchers from The Wistar Institute discovered a novel form of crosstalk among tumor cells...

Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment...

Credit: ETH Zurich T-cells are one of the immune system's major weapons. They detect the body's cells infected with a...

Scientists have created mini biological models of human primary liver cancers, known as organoids, in the lab for the first...

NOVEMBER 13, 2017, NEW YORK - Ludwig Cancer Research has released the scope of its participation at this year's Annual...

LUGANO, Switzerland, 13 November, 2017 - ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication...

(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing´s sarcoma at the Connective...

Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain...

Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done...

NOVEMBER 10, 2017, New York -- A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig...

Credit: Figure by Anna T. Prescott. A new Dartmouth-led study finds that patients with depression and advanced cancer live longer...